NCT05121974 - Tebipenem Trial in Children With Shigellosis | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

March 15, 2025

Study Completion Date

August 17, 2026

Conditions

Shigellosis

Interventions

DRUG

Tebipenem Pivoxil

Tebipenem (brand name: Orapenem) is a broad-spectrum orally administered antibiotic, from the carbapenem subgroup of β-lactam antibiotics.

DRUG

Azithromycin

Oral Azithromycin antibiotic (Macrolides)

DRUG

Ceftriaxon

IV Ceftriaxone (Cephalosporin)

Trial Locations (1)

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka